Nephros(NEPH)

持股变动声明

Nephros(NEPH)03-15 04:35

$Nephros(NEPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001048462-24-000011  Size: 6 KB 网页链接查看全文

股东委托书协议

Nephros(NEPH)04-13 04:05

$Nephros(NEPH)$ DEF 14A Other definitive proxy statements Accession Number: 0001493152-24-014442  Act: 34  Size: 1 MB 网页链接查看全文

持股变动声明

Nephros(NEPH)03-15 04:45

$Nephros(NEPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001048462-24-000012  Size: 12 KB 网页链接查看全文

年度财报

Nephros(NEPH)03-16 04:35

$Nephros(NEPH)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001493152-24-010107  Act: 34  Size: 7 MB 网页链接查看全文

当期报告

Nephros(NEPH)03-08 05:25

$Nephros(NEPH)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001493152-24-009216  Act: 34  Size: 345 KB 网页链接查看全文

其他

Nephros(NEPH)04-13 04:15

$Nephros(NEPH)$ ARS Annual Report to Security Holders Accession Number: 0001493152-24-014448  Act: 34  Size: 1 MB 网页链接查看全文

其他

Nephros(NEPH)04-13 04:15

$Nephros(NEPH)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001493152-24-014447  Act: 34  Size: 709 KB 网页链接查看全文

TOPVIEW |2021.7.8 Bio-market主要涨跌一览

蹊之美股生物医药2021-07-09 20:55

作者：林出
微信公众号：蹊之美股生物医药 / CaesarBiotech
Gainers: 
Aerpio Pharm (ARPO) +63.16%
GBS Inc (GBS) +33.22%
Alterity Therapeutics (ATHE) +27.85%
9 Meters Biopharma (NMTR) +20.39%
F-star Therapeutics (FSTX) +9.13%
Los...查看全文

$Nephros(NEPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000914190-21-000008  Size: 13 KB 网页链接

$Nephros(NEPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000914190-21-000009  Size: 9 KB 网页链接

$Nephros(NEPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000914190-21-000010  Size: 9 KB 网页链接

$Nephros(NEPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000914190-20-000423  Size: 8 KB 网页链接

$Nephros(NEPH)$ 内部交易: 2020-11-19,总裁 & CEO,Astor Andrew ,买入,1000普通股, $5.87

$Nephros(NEPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000914190-20-000420  Size: 14 KB 网页链接

$Nephros(NEPH)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0000914190-20-000398  Size: 6 KB 网页链接

$Nephros(NEPH)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001493152-20-020593  Act: 34  Size: 4 MB 网页链接

$Nephros(NEPH)$ 8-K Current report, items 2.02, 5.02, and 9.01 Accession Number: 0001493152-20-020597  Act: 34  Size: 308 KB 网页链接

$Nephros(NEPH)$ 8-K Current report, item 5.02 Accession Number: 0001493152-20-020123  Act: 34  Size: 25 KB 网页链接